-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Denali Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2024.
- Denali Therapeutics Inc. Return On Equity for the quarter ending March 31, 2024 was -11.5 %, a 71.4% increase year-over-year.
- Denali Therapeutics Inc. annual Return On Equity for 2023 was -13.5 %, a 62.1% increase from 2022.
- Denali Therapeutics Inc. annual Return On Equity for 2022 was -35.7 %, a 27.4% decline from 2021.
- Denali Therapeutics Inc. annual Return On Equity for 2021 was -28 %, a 403% decline from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)